Plan Amendment and Termination Contract Clauses (81)

Grouped Into 2 Collections of Similar Clauses From Business Contracts

This page contains Plan Amendment and Termination clauses in business contracts and legal agreements. We have organized these clauses into groups of similarly worded clauses.
Plan Amendment and Termination. The Board may amend or terminate the Plan as it shall deem advisable; provided that no change shall be made that increases the total number of Shares reserved for issuance pursuant to Awards (except pursuant to Section 13 above) unless such change is authorized by the shareholders of the Company. A termination or amendment of the Plan shall not materially and adversely affect a Participant's vested rights under an Award previously granted to him or her, unless the Participant consents in... writing to such termination or amendment. Notwithstanding the foregoing, the Committee may amend the Plan to comply with changes in tax or securities laws or regulations, or in the interpretation thereof. View More Arrow
Found in ADVANCED ENVIRONMENTAL RECYCLING TECHNOLOGIES INC contract
View All 7 Similar Clauses
Plan Amendment and Termination. The Board may amend or terminate the Plan as it shall deem advisable; provided that no change shall be made that increases the total number of Shares reserved for issuance pursuant to Awards (except pursuant to Section 13 above) unless such change is authorized by the shareholders stockholders of the Company. A termination or amendment of the Plan shall not materially and adversely affect a Participant's vested rights under an Award previously granted to him or her, unless the Participant... consents in writing to such termination or amendment. Notwithstanding the foregoing, the Committee may amend the Plan to comply with changes in tax or securities laws or regulations, or in the interpretation thereof. Furthermore, neither the Company nor the Committee shall, without stockholder approval, either (a) allow for a "repricing" within the meaning of federal securities laws applicable to proxy statement disclosures, or (b) cancel an outstanding Option whose exercise price is greater than Fair Market Value at the time of cancellation for the purpose of reissuing the Option to the Participant at a lower exercise price or granting a replacement award of a different type. View More Arrow
Found in Gevo, Inc. contract
Plan Amendment and Termination. The Board may amend or terminate the this Plan as it shall deem advisable; provided that no change shall be made that increases the total number of Shares reserved for issuance pursuant to Awards (except pursuant to Section 13 above) 9 above), unless such change is authorized by the shareholders stockholders of the Company. Company to the extent required by Applicable Law. A termination or amendment of the this Plan shall not materially and adversely affect a Participant's vested rights 18... under an Award previously granted to him or her, her unless the Participant consents in writing to such termination or amendment. Notwithstanding the foregoing, the Committee may amend the this Plan to comply with changes in tax or securities laws or regulations, or in the interpretation thereof. View More Arrow
Found in Mohawk Group Holdings, Inc. contract
Plan Amendment and Termination. The Board may amend or terminate the this Plan as it shall deem advisable; provided that no change shall be made that increases the total number of Shares reserved for issuance pursuant to Awards (except pursuant to Section 13 12 above) unless such change is authorized by the shareholders stockholders of the Company. Company to the extent required by Applicable Law. A termination or amendment of the this Plan shall not materially and adversely affect a Participant's vested rights under an Award... previously granted to him or her, unless the Participant consents in writing to such termination or amendment. Notwithstanding the foregoing, the Committee may amend the this Plan to comply with changes in tax or securities laws or regulations, or in the interpretation thereof. Furthermore, neither the Company nor the Committee shall, without stockholder approval, amend this Plan either (a) to materially expand the class of Eligible Persons under this Plan, (b) to materially increase the benefits accruing to Participants under this Plan, (c) to materially extend the term of this Plan, (d) to expand the types of Awards available for issuance under this Plan, (e) to allow for a "repricing" within the meaning of either the federal securities laws applicable to proxy statement disclosures or other applicable governance standards, or (f) to cancel an outstanding Option whose exercise price is greater than Fair Market Value at the time of cancellation for the purpose of reissuing the Option to the Participant at a lower exercise price or granting a replacement award of a different type. View More Arrow
Found in Tyra Biosciences, Inc. contract
View Variations (7) Arrow
Plan Amendment and Termination. The Plan may be revised, modified, or terminated at any time in the sole discretion of the Compensation Committee or the Board. Adopted: January 6, 2016 Amended and restated: January 7, 2020 Amended and restated: November 30, 2020, effective as of January 1, 2021 4 EX-10.7 3 d63231dex107.htm EX-10.7 EX-10.7 Exhibit 10.7 GLOBAL BLOOD THERAPEUTICS, INC. AMENDED AND RESTATED CASH INCENTIVE BONUS PLAN 1. Purpose This Amended and Restated Cash Incentive Bonus Plan (the "Plan") is intended to provide... an annual incentive for superior work and to help motivate eligible employees of Global Blood Therapeutics, Inc. (the "Company") toward even higher achievement and business results, to further tie their goals and interests to those of the Company and its stockholders and to help enable the Company to attract and retain highly qualified employees. This Plan is intended to cover (i) eligible employees of the Company and (ii) eligible employees of the Company's wholly owned subsidiary Global Blood Therapeutics GmbH registered in Switzerland. For purposes of this Plan, the term "Company" is used herein to refer to either Global Blood Therapeutics, Inc. or Global Blood Therapeutics GmbH. Temporary employees are not eligible to participate in the Plan, and sales employees who are eligible to participate in sales incentive compensation plans of the Company are not eligible to participate in the Plan. View More Arrow
Found in Global Blood Therapeutics, Inc. contract
Plan Amendment and Termination. The Plan may be revised, modified, or terminated at any time in the sole discretion of the Compensation Committee or the Board. Adopted: January 6, 2016 Amended and restated: effective: January 7, 2020 Amended and restated: November 30, 2020, effective as of effective: January 1, 2021 Amended effective: January 1, 2022 4 ACTIVE/112960897.2 EX-10.7 3 d63231dex107.htm 2 gbt-ex10_7.htm EX-10.7 EX-10.7 Exhibit 10.7 GLOBAL BLOOD THERAPEUTICS, INC. AMENDED global blood therapeutics, INC.AMENDED AND... RESTATED U.S. CASH INCENTIVE BONUS PLAN 1. Purpose This Amended and Restated U.S. Cash Incentive Bonus Plan (the "Plan") is intended to provide an annual incentive for superior work and to help motivate eligible U.S. employees of Global Blood Therapeutics, Inc. (the "Company") toward even higher achievement and business results, to further tie their goals and interests to those of the Company and its stockholders and to help enable the Company to attract and retain highly qualified employees. This Plan is intended to cover (i) eligible U.S. employees of the Company 2. Participants Except as provided in the remainder of this paragraph, each full-time and (ii) eligible employees part-time U.S. employee of the Company's wholly owned subsidiary Global Blood Therapeutics GmbH registered Company who is employed for more than 30 hours a week and employed on the last day of the applicable Plan Year (except as specifically provided in Switzerland. For purposes Section 7) whose employment start date is before October 1st of this Plan, the term "Company" is used herein to refer to either Global Blood Therapeutics, Inc. or Global Blood Therapeutics GmbH. applicable Plan Year may participate in the Plan (each, a "Participant"). Temporary employees are not eligible to participate in the Plan, and sales employees who are eligible to participate in sales incentive compensation plans of the Company are not eligible to participate in the Plan. View More Arrow
Found in Global Blood Therapeutics, Inc. contract
View Variation Arrow